Foglime Met Sustained Release Tablet 10/500 mg

Adult dose

This medication is generally administered once a day with the evening meal. The maximum dosage is 10 mg of dapagliflozin/2000 mg of extended-release metformin once daily, administered as 2 tablets of 5 mg/1000 mg. In cases where the patient has no prior experience with diabetes treatment and adequate blood sugar control cannot be achieved with monotherapy, initial therapy can begin with 5 mg/500 mg or 10 mg/500 mg once daily.

This medication is used for the treatment of diabetes and helps to control blood sugar levels. Rarely, during the use of this medication, a serious condition called lactic acidosis may occur. If symptoms such as difficulty breathing, muscle pain, or fatigue appear, consult a doctor immediately. When taking other diabetes medications, hypoglycemic symptoms may occur, so blood sugar levels should be monitored closely. Patients with impaired kidney function, dehydration, severe infections, or heart-related problems should not take this medication, and the drug should be discontinued around the time of surgery or radiological examinations. Women who are pregnant or breastfeeding should not take this medication for safety. Elderly individuals or those with decreased kidney function should consult a doctor before taking this medication, and kidney function should be regularly monitored during treatment. This medication can cause genital infections or urinary tract infections in some patients, so treatment should be sought immediately if infection symptoms arise. Patients with reduced fluid volume or risk of low blood pressure should take caution while using this medication, and may temporarily stop it if necessary. During treatment, watch for signs of hypoglycemia, and dose adjustments may be required when used with insulin or other hypoglycemic agents. Patients with underlying conditions such as liver or kidney disease, or heart failure should use this medication only under medical supervision. In cases of overdose, seek immediate medical attention for appropriate treatment; the safety of this medication in children has not been established. This medication does not significantly affect driving or machine operation, but caution is needed as symptoms like dizziness may occur. Store this medication out of reach of children, and keep it in the original container to maintain quality.

Serious side effects

Lactic acidosis, severe hypoglycemia, severe allergic reactions (hypersensitivity), acute kidney injury, renal impairment, acute myocardial infarction, shock, acute or chronic metabolic acidosis, diabetic pre-coma, congestive heart failure, acute cholecystitis, Guillain-Barré syndrome, atrial fibrillation, perineal necrosis, urinary sepsis, pyelonephritis, acute kidney injury, severe edema (systemic edema), severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis

Mild side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, pain during urination, polyuria, nocturia, vulvar itching, genital itching, increased hematocrit, decreased creatinine clearance in the early treatment phase, dyslipidemia, elevated serum creatinine in the early treatment phase, elevated blood urea, weight loss, abdominal pain, dyspepsia,

Store this medication in a tightly closed container to prevent air or moisture from entering. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. This way, the effectiveness of the medication is maintained and degradation can be avoided.

Appearance

Pink, oval, film-coated tablets with a biconvex shape on both sides

Package unit

30 tablets/bottle